Counteracting Alzheimer's disease via somatic TERT activation
Nat Aging
.
2021 Dec;1(12):1081-1082.
doi: 10.1038/s43587-021-00145-0.
Authors
Yuan Fu
1
,
Guojun Bu
2
3
,
Takahisa Kanekiyo
2
3
,
Jing Zhao
4
5
Affiliations
1
Department of Neurology, The Fourth Hospital of Harbin Medical University, Harbin, China.
2
Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
3
Neuroregeneration Laboratory, Center for Regenerative Medicine, Mayo Clinic, Jacksonville, FL, USA.
4
Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA. Zhao.Jing@mayo.edu.
5
Neuroregeneration Laboratory, Center for Regenerative Medicine, Mayo Clinic, Jacksonville, FL, USA. Zhao.Jing@mayo.edu.
PMID:
37117526
DOI:
10.1038/s43587-021-00145-0
No abstract available
Publication types
Comment
MeSH terms
Alzheimer Disease* / diagnosis
Brain
Humans
Telomerase* / genetics
Substances
TERT protein, human
Telomerase